×
Please click
here
if you are not redirected within a few seconds.
All
Images
News
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Vertex Pharmaceuticals (VRTX) Earnings Expected to Grow: Should You Buy?
Yahoo Finance
Vertex (VRTX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report.
6 hours ago
A nephrologist's perspective on APOL1-mediated kidney disease
Vertex Pharmaceuticals
Dr. Ogo Egbuna leads clinical development for the genetic kidney disease programs at Vertex Pharmaceuticals. Learn more about APOL1-mediated...
8 hours ago
Vertex jumps to TreeFrog to enhance production of Type 1 diabetes cell therapy candidates
Fierce Pharma
Helping Vertex develop three pipeline candidates in Type 1 diabetes will be French cell therapy developer and manufacturer TreeFrog...
5 days ago
Pharmalittle: We're reading about Cigna biosimilar plans, a Vertex deal in South Africa, and more
STAT
The World Health Organization says new evidence shows the extensive overuse of antibiotics during the Covid-19 pandemic worldwide.
3 days ago
VERTEX AND TREEFROG THERAPEUTICS ANNOUNCE LICENSING AGREEMENT AND COLLABORATION TO ...
PR Newswire
PRNewswire/ -- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and TreeFrog Therapeutics today announced that Vertex has obtained an...
6 days ago
Alpine's data room was the most exclusive club in biotech. Then Vertex became the VIP
Fierce Biotech
After Alpine Immune Sciences presented initial data for the kidney disease therapy povetacicept at a conference in November 2023,...
6 days ago
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Purchased by PGGM Investments
MarketBeat
PGGM Investments boosted its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 88.9% in the 4th...
8 hours ago
Vertex Joins Oracle ISV Accelerator Program
CPA Practice Advisor
The Vertex Accelerator offering has been steadily delivering a “near push-button” experience for more than 175 global customers looking to...
4 days ago
Its blockbuster cystic fibrosis treatment costs $300,000 a year. Now Vertex wants to solve the opioid crisis
Financial Times
So effective is Vertex Pharmaceuticals' blockbuster cystic fibrosis (CF) drug, Trikafta, that studies project it could extend the lives of...
3 days ago
Vertex Announces European Commission Approval for KALYDECO® to Treat Infants With Cystic Fibrosis Ages 1 Month ...
Business Wire
Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for the label expansion of KALYDECO®...
3 days ago